Lipid profile of cerebrospinal fluid in multiple sclerosis patients: a potential tool for diagnosis

Area of Science:

• Neuroscience
• Biochemistry
• Immunology

Background:

• Multiple sclerosis (MS) is a complex neuropathology where the immune system attacks myelin.
• Lipids, key myelin components, are implicated in MS, but specific alteration patterns remain debated.
• Understanding lipid changes in MS is crucial for diagnosis and treatment.

Purpose of the Study:

• To investigate lipid alterations in cerebrospinal fluid (CSF) of MS patients at diagnosis.
• To identify a potential lipidomic signature for MS diagnosis.
• To explore the role of specific lipid families, such as fatty acids (FAs), in MS.

Main Methods:

• A lipidomic approach was employed to analyze CSF samples from MS patients.
• Hierarchical clusterization and supervised methods were used for patient classification.
• Targeted analysis focused on specific lipid species and fatty acids.

Main Results:

• CSF from MS patients showed differences in 155 lipid species at diagnosis.
• A distinct lipidomic signature comprising 15 molecules from five lipid families was identified.
• Specific alterations in fatty acids 18:3n3 and 20:0 (arachidic acid) were observed.

Conclusions:

• A CSF lipidomic signature exists in MS patients at the time of diagnosis.
• This signature holds potential as a diagnostic tool for multiple sclerosis.
• Further research can validate these findings for clinical application.